Basics Forte Biosciences, Inc. IPO Date: April 10, 2017 Sector: Healthcare Industry: Biotech Market Cap: $115.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 4.06% Avg Daily Range (30 D): $0.75 | 5.76% Avg Daily Range (90 D): $0.59 | 6.32% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .1M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 155 Avg Trade Size (Sh.) (30 D): 91 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 80 Avg Inst. Trade: $1.75M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.65M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.54M Avg Closing Trade (30 D): $.74M Avg Closing Trade (90 D): $.74M Avg Closing Volume: 14.44K     News Jul 4, 2025 @ 10:00 AM Forte and Sequence Partner to Power Web3 Monetizat... Source: Bela Pandya (Forte Ceo) Mar 25, 2024 @ 4:00 PM What Makes Forte Biosciences (FBRX) a New Buy Stoc... Source: Zacks Equity Research Dec 13, 2023 @ 1:29 PM Research Frontiers And 3 Other Stocks Under $1 Ins... Source: Avi Kapoor Dec 11, 2023 @ 1:34 PM RiskOn International And 3 Other Stocks Under $2 I... Source: Avi Kapoor Nov 24, 2023 @ 11:38 AM Insiders Buying Vintage Wine Estates And 3 Other S... Source: Lisa Levin Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.37 $3.18 $-12.17 Diluted EPS $-1.37 $3.18 $-12.17 Revenue $ M $ 1.31M $ 1.31M Gross Profit $ $ $ Net Income / Loss $ -15.66M $ -7.16M $ -35.48M Operating Income / Loss $ -16.12M $ -7.35M $ -36.6M Cost of Revenue $ $ $ Net Cash Flow $ 23.61M $ 5.88M $ -14.88M PE Ratio     Splits Aug 28, 2024:   1:25